A Study of ATB1651 in Adults With Mild to Moderate Onchomycosis
Clinical trial NCT06327295 · RECRUITING
Trial details
- NCT number
- NCT06327295
- Sponsor
- AmtixBio Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2025-06-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.